Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Lilly claims novel 5-HT/norepinephrine reuptake inhibitors for pain and other uses

July 1, 2004

Six related series of opioid analgesics presented by Gruenenthal

July 1, 2004

Vernalis and Biogen Idec collaborate on adenosine A2A receptor antagonists

July 1, 2004

Preclinical and clinical evidence for the efficacy of transdermal rotigotine in PD

June 30, 2004

ACR-16 reported safe as adjunct therapy in patients with advanced PD

June 30, 2004

Stalevo reported safe and effective in improving motor fluctuations in PD patients

June 30, 2004

FDA lifts clinical hold on ocinaplon

June 30, 2004

Gepirone ER NDA deemed not approvable

June 30, 2004

Results of recent Lexapro pediatric study

June 30, 2004

Study suggests simvastatin can prevent silent brain infarct

June 29, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...